Increasing the biosafety of analytical
systems in the clinical laboratory by Truchaud, A. et al.
Journal of Automatic Chemistry, Vol. 16, No. 2 (March-April 1994), pp. 67-70
Increasing the biosafety of analytical
systems in the clinical laboratory
Prepared for the International Federation of
Clinical Chemistry by A. Truchaud*,
P. Schnipelsky, H. L. Pardue, J. Place and K. Ozawa
Biosafety is an important part of the know-how of all clinical
laboratory professionaL. Biosafely must have high priority in the
design and use of analytical systems. Attention should be focused
on reducing the handling, of biological specimens, reducing
biohazards to laboratory personnel, and on improving the labelling
and containment of biohazardous materials. In thispaper, biosafety
issues are discussed in relation to the design of analytical systems,
their use and maintenance.
Introduction
Biological materials, particularly blood and urine, may
present health risks to laboratory workers. These risks are
dramatically increased when infectious agents, such as the
hepatitis viruses and HIV, are present [1, 2]. Other
compounds, such as carcinogens, toxic organic com-
pounds, teratogens and some metals, that are present in
reagents also pose biosaIi:ty hazards. A number of
organizations have produced guidelines which are tbcused
on general rules for laboratory organization and handling
of specimens [3-5].
A major recent development in clinical laboratories is the
increasing use ofrobotics in automated analytical systems.
An intelligent approach is to take biosafety into account,
ti’om the start, in developing new systems. Biosafety should
be a system requirement like precision, accuracy or
throughput [6, 7]. The purpose of this paper is not to
produce detailed specifications; but to demonstrate the
advantages which would result from efforts in this area.
Specimen collection, labelling and transportation
Biosafety is important in every aspect of laboratory work
(see figure 1). Precautions should begin with specimen
collection; these have been extensively discussed in the
literature I-3, 4-]. The problems of specimen collection,
especially those of specimen containers, should be
considered an integral part of {he analytical system.
Most of the existing specimen collection devices were
developed independently of the analytical systems. The.
tbllowing highlights some of their defects and suggests
improvements.
Open syringes are potentially dangerous. Closed blood
specimen collection systems, such as evacuated sampling
devices and tubes, should be used to collect blood samples.
A systematic approach linking the sample collection step
to analysis of the sample requires that the collection tube
be compatible with the analyser. Many analytical systems
can take a sample directly from primary tubes. Standard-
ization ofspecimen collection tubes is necessary to reduce
the number of different sizes employed on different types
of instrument carousels.
New technologies that take biosafety into consideration
are needed. Containers should be designed for collection
of specimens other than blood, such as urine and stool,
and for their safe transport and handling. Procedures for
avoiding infection from cerebrospinal fluid and other types
of body fluids, and from stool, should be specified and
followed.
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Figure 1. Biosafety is involved in every task that is carried out
in the clinical laboratory, from specimen collection through
maintenance and waste disposal.
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Table 1. Biosafety in the handling of whole blood.
Step
Centrifugation of blood
Centrifugation of
microhaematocrit tubes
Mixing of samples for
blood gas analysis
Recommended action
--Use tubes of a size and
external diameter that exactly
fits the buckets
--Use plastic tubes to reduce
breakage and for ease of
disposal
--Use clear bucket covers to
allow inspection of contents
--Seal the tubes to avoid
aerosol formation
mUse a sealed rotor
--Use plastic (instead of glass)
capillaries
mUse a robotic mixer [16]
--Use an arterial blood
collection kit
’Such kits are produced by a variety of manufacturers, such as
Radiometer, Becton Dickinson, Terumo and Ciba-Corning.
As for labelling of specimens, some guidelines recommend
a special label indicating a high risk of infection for some
specimens. All specimens should be treated as potentially
hazardous [8]. Biohazards are decreased if the amount
of handling the specimen undergoes is reduced. To this
end, a reliable identification system helps. The labels must
have one kind of identification that can easily be read by
eye. If possible, identification that can be read by a
machine should also be attached to the specimen at the
time of collection [9]. Machine-readable labels must be
compatible with the sample code reader of the analytical
system. Again, it would be useful to standardize the codes
employed by different analytical systems.
The main risks in specimen transport are breakage of the
specimen container, leakage of its contents due to poor
sealing, and partial or complete loss of the specimen.
Standardization of the container specifications would
allow a standardization of transport devices [5]. A new
trend within some hospitals is to mechanize specimen
transport to the laboratory using closed containers which
can be thermally controlled.
Preanalytical treatment of blood specimens
In order to separate plasma or serum, some analytical
systems include an integrated separation step using
filtration or centrifugation [10-12]. However, the tech-
nique most often used for large batches of specimens is
centrifugation without any special devices.
Table lists the steps that may be taken to reduce the
risk of contamination from processing blood. The main
risk in centrifugation and in mixing whole blood is
contamination by aerosol from open and broken tubes.
When whole bood has to be mixed, the risk lies in breakage
of the specimen containers and injury to the operator,
resulting in infection. These hazards can be avoided once
they are identified.
An attractive innovation is the concept of automated
serum or plasma processing station, in which centrifugation
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and transfer of specimen into closed samples cups and
secondary storage tubes are automated [ 13]. It is possible
to automate not only the separation process but the whole
sample handling process [14].
In blood cell counting, the contents of the tube require
mixing before dilution for counting. The operator holds
the two ends of the tube between his or her thumb and
index finger. The use of the analytical systems for
haematology which have built-in automated mixing
devices is desirable because it avoids this biohazard. Blood
smears for microscopic examination should be prepared
robotically for the same reason [15].
Specimen sampling
In order to avoid transfers of blood, plasma or serum,
which always pose a biohazard, specimens should be
sampled from the primary tubes. Blood counting systems
now have sampling modules that are able to withdraw
the specimen from a closed tube through a probe which
penetrates the cap. Some chemistry systems are able to
withdraw a plasma or serum specimen through a tube
that not only penetrates the cap but senses the surface of
the fluid specimen [17, 18]. This, or an equivalent
approach avoiding manual transfers, should become a
standard feature for automated systems.
The sampling probes used in analysers, which are sharp
and move at high speed in the carousel area, may pose
a hazard to the operator. Probes should be equipped with
detectors that stop the process in the case ofan obstruction
(which is already the case on some robotic systems), and
the operator should be ’locked out’ of some areas of the
analyser when the probe is in operation.
One option is the continuous input of specimens in racks
which are automatically moved to the sample area [19].
Ideally, all analysers should use the same form of sample
racks which would again reduce the need for transfer of
blood tubes. In addition the system for holding the
individual samples should be common from the point of
reception to the point ofdisposal or storage ofthe analysed
samples.
To avoid carry-over effects, some analysers use disposable
tips which are affixed by a robotic arm and discarded
after sample delivery. Aerosol contamination is possible
in such automated systems because this type of pipettor
uses air displacement to eject used tips, contaminating the
pipettor itself. This biohazard can be avoided with the use
of pipette tips manufactured with plugs that serve as
aeorosol barriers.
In bacteriology, some automated systems for blood
cultures allow the cultures to remain closed. Whole bood
is introduced into the container through the cap, and gas
samples are aspirated through the cap and transferred for
CO2 measurement. Recently, an automated colorimetric
microbial detection system was described using a CO2
detection system built into the bottom of each bottle and
separated from the culture medium by a semipermeable
membrane. As CO2 is produced it crosses the membrane.
The decrease in pH causes a colour change which is
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culture bottle [20]. Handling steps can be further reduced
in another automated blood culture system in which the
CO2 is measured within the specimen container by means
of infra-red spectrometry (ARGOS Blood Culture Auto-
mated System, Pasteur Diagnostics, France). As a further
example, an erythrocyte sedimentation reader has been
developed where a video image processing system scans
the erythrocyte sedimentation process directly through a
dedicated tube I-21].
Biohazards in reagents and quality-control materials
Reagents used in the clinical laboratory may pose a
biohazard. For example, the ethidium bromide that is
used for staining DNA in cytofluorometry is potentially
carcinogenic to the operator. Quality-control and cali-
bration materials must be free of known infectious
agents. However, no guarantee can be given that they
are free of any infectious agerits. Precautions against
infectious agents not yet recognized, or not yet detectable,
have to be taken into consideration by }oth the supplier
and user of these products. If possible, materials derived
tiom human blood should be avoided.
Several practical points should be made. Quality-control
materials and reagents that are supplied in sealed vials
requiring sharp instruments (such as scissors) for opening
them should be avoided. Second, refrigeration of reagents
remaining on the analyser is often desirable because it
reduces microbial growth. Third, recycling of reagents,
which is possible in some systems, should be avoided
because it leads to a high risk ofcontaminating the system
with infectious agents. Systems should be designed to make
recycling of reagents impossible.
Storage and handling of specimens and reagents
When cold storage rooms, refrigerators or freezers are used
for storage of specimens or reagents, they should be
equipped with separate compartments for specimens
and reagents. The specimen areas should be carefully
disinfected.
When uncapped cups are used on carousels, it is often
difficult to remove them without spilling the serum or
plasma. Commonly used anti-evaporation barriers may
limit this biohazard.
Waste disposal
Currently, specimens or reaction mixtures from analysers
go down the drain like waste water. Several alternatives
are being developed. By sealing disposable cuvettes after
use [17-1, disposal of liquid waste becomes similar to solid
waste disposal. Liquids can be treated with disinfectant
beibre disposal, or collected in containers which are then
safely disposed of[22]. Sensors should be used to prevent
overflow of the containers, which should be located in a
place with limited risk of contaminating either the
analyser or the operator. Further, liquid waste containers
should be designed in a way that prevents contact between
the waste and the operator’s hands.
Solid waste is produced by analytical systems that use
reagents on solid supports (strips, films, coated microtitre
plates) or disposable reagent containers. Solid waste can
block an analyser mechanically, resulting in contamination
of the analyser with patient sera. We suggest that solid
waste should fall into containers with a sensor to detect
when they are full.
Techniques for the recovery of materials from waste
should be developed in order to encourage biosafety.
Manufacturers should provide precise information not
only on how to decontaminate, but how to treat the waste
(by crushing, burning, etc.) in a manner that will allow
recovery of the raw materials. This type of conservation
would balance the high cost of improving biosafety.
Contaminated materials create special challenges in this
regard.
Maintenance procedures and decontamination
Preventive maintenance has a role in biosafety [23].
Cleaning and disinfection procedures should be included
and clearly explained in users’ manuals [24]. These steps
could be incorporated into the system software, rather
like a diagnostic program. The components of the system
should be decontaminated (such as reagents, samples,
used tubes, seal, membranes and filters) should be
identified and the appropriate disposal methods should
be given.
Field service engineers should be reminded that sharp
tools must not be used in disassembling parts which are
in contact with blood or blood derivative.
The non-disposable mechanical parts involved in fluid
handling (diluter valves, pump cylinders, heaters etc.)
should be designed so that they do not come into contact
with the specimen. If the part has to come into contact
with possibly contaminated fluids, a disposable part
should be designed. A particularly good example is the
disposable septum which replaces the valve to aspirate
alternatively specimen, calibrants or buffers in a blood
gas analyser [25].
Decontamination is performed in a machine used in
histopathology for cutting frozen sections [26]. Analogous
systems could well be developed to other clinical laboratory
instruments to reduce biohazards for the operator.
Biosafety assurance
The design of analytical systems can improve biosafety.
Table 2 summarizes several of the features which have as
their objectives protection of instrument operators and
service personnel. The small objective is to reduce the
possibility of contamination and aerosol formation from
fluid system leaks.
Many protocols have been published concerning the
analytical performance of instruments and automated
systems. New protocols concerning biosafety aspects
should be developed; for example, a dynamic micro-
biological test was applied to the evaluation of sealed
containers for use in centrifuges [27]. Other protocols
should be suggested by manufacturers.
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Table 2. Improving biosafety through instrument design.
Objectives and recommended
Feature action
Metal or plastic shield
Connectors
Keyboards
Air flow
Vacuum and pressure
systems
Liquid drip tray
Biohazard labels
--To isolate the electronic, fluidic
and analytical areas and
components
--To reduce aerosol formation and
other forms of contamination
--.Use of quick release, self-sealing
plastic tubing for fluid lines,
especially waste disposal lines
---Designed for use by the
instrument operator, they
should be protected, flat and
easy to clean
-Alternatively, keyboards may be
replaced by tactile screens,
which are easy to clean
--Use of separate cooling fan or
filtered air flow for power
supply and circuit board
--Flow must not be directed
through the sample handling
area betbre reaching other areas
--Flow from instrument must not
be directed at the operator
--Lines used to withdraw
biohazardous waste must be
equipped with hydrophobic
filters located between the
pump and the container
--When possible, sample handling
and probe washing areas should
be equipped with plastic tray
with drainage into a waste
container
--Instrument parts that may
come into contact with patient
specimens or waste should be
labelled with the internationally
recognized biohazard symbol
The training programme tbr the laboratory team should
include instruction on biosaity, as well as productivity
and the clinical relevance of the results. There should be
a systematic approach to biosaity and this should be
considered when selecting equipment or introducing a
new test procedure.
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